You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Basophilic, Acute

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

Recruiting
  • B-Cell Non Hodgkin Lymphoma
  • B-Cell Acute Lymphoblastic Leukemia
  • anti-CD19 CAR T-cells
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023

Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • Hetrombopag Olamine
  • (no location specified)
Jul 5, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia

Recruiting
  • Acute Leukemia
  • No intervention, observation study
  • Hangzhou, Zhejiang, China
    Clinical research ethics committee of the first affiliated hospi
Oct 6, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • QH103 Cell Injection
  • +2 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Sep 21, 2023

Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Palo Alto, California
    Stanford University
Aug 14, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Study of miRNA-155 in Acute Leukemia

    Not yet recruiting
    • Acute Leukemia
    • BM aspirate
    • (no location specified)
    Mar 30, 2023

    PET Tracer Based FDG Signal for Predicting Prognosis in Acute

    Enrolling by invitation
    • Acute Myeloid Leukemia
    • No intervention
    • Guangzhou, Guangdong, China
      First Affiliated Hospital of Jinan University
    Jun 22, 2023

    Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations Trial (ziftomenib)

    Available
    • Acute Lymphoblastic Leukemia, With Appropriate Mutations
    • Acute Myeloid Leukemia, With NPM1 Mutations
    • (no location specified)
    Feb 10, 2023

    Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

    Not yet recruiting
    • Pediatric Acute Lymphoblastic Leukemia
    • +2 more
    • Sleep ALL Night
    • Boston, Massachusetts
    • +1 more
    May 10, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

    Not yet recruiting
    • C-KIT Mutation
      • (no location specified)
      Nov 2, 2023

      Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

      Recruiting
      • Acute Myelogenous Leukemia (AML) Due to Therapy
      • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
      • Orange, California
      • +2 more
      Nov 30, 2022

      Enteral Nutrition in Children Treated for Acute Lymphoblastic

      Active, not recruiting
      • Leukemia, Lymphoblastic
      • enteral or parenteral nutritional support
      • Vandœuvre-lès-Nancy, France
        CHRU Nancy
      Oct 26, 2023

      Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

      Recruiting
      • Refractory/Relapse Acute Myeloid Leukemia
      • Kunming, Yunnan, China
        Department of Hematology,920th Hospital of Joint Logistic Suppor
      Mar 28, 2023

      Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

      Recruiting
      • Acute Myeloid Leukemia
      • Suzhou, Jiangsu, China
        Qiu Huiying
      Mar 28, 2023

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • +2 more
      • CPI 613
      • +3 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      May 10, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Miltenyi CliniMACS Prodigy ® system
      • (no location specified)
      Mar 23, 2023

      Mold Infections in Children During Leukemia Treatment

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • Acute Lymphoblastic Leukemia
        • Odense, Denmark
          Rasmus Møller Duus
        Mar 7, 2023

        Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

        Recruiting
        • Acute Lymphoblastic Leukemia
          • Trieste, Italy
            IRCCS Burlo Garofolo
          Mar 20, 2023

          Acute Myeloid Leukemia Trial in Taipei

          Enrolling by invitation
          • Acute Myeloid Leukemia
            • Taipei, Taiwan
              National Taiwan University Hospital
            Aug 9, 2023

            Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

            Recruiting
            • Relapsed/Refractory Acute Myeloid Leukemia
            • B7-H3 target, CAR gene modified gdT cell injection
            • Hangzhou, Zhejiang, China
              The First Affiliated Hospital， Zhejiang University School of Med
            Feb 15, 2023

            Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

            Not yet recruiting
            • Acute Myeloid Leukemia
            • +2 more
            • Los Angeles, California
            • +9 more
            Jun 27, 2023